Agitation and Aggression in Alzheimer's Disease (AD): Study Design and Outcome Measures in a Trial of Scyllo-inositol (ELND005 HARMONY AD Study).

MLA

Abushakra, Susan, et al. “Agitation and Aggression in Alzheimer’s Disease (AD): Study Design and Outcome Measures in a Trial of Scyllo-Inositol (ELND005 HARMONY AD Study).” Neurobiology of Aging, vol. 35, Mar. 2014, p. S1. EBSCOhost, https://doi.org/10.1016/j.neurobiolaging.2014.01.030.

APA

Abushakra, S., Bairu, M., Kesslak, P., Kurth, M., Miller, D., & Lyketsos, C. (2014). Agitation and Aggression in Alzheimer’s Disease (AD): Study Design and Outcome Measures in a Trial of Scyllo-inositol (ELND005 HARMONY AD Study). Neurobiology of Aging, 35, S1. https://doi.org/10.1016/j.neurobiolaging.2014.01.030

Chicago

Abushakra, Susan, M. Bairu, P. Kesslak, M. Kurth, D. Miller, and C. Lyketsos. 2014. “Agitation and Aggression in Alzheimer’s Disease (AD): Study Design and Outcome Measures in a Trial of Scyllo-Inositol (ELND005 HARMONY AD Study).” Neurobiology of Aging 35 (March): S1. doi:10.1016/j.neurobiolaging.2014.01.030.